Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Evaluating a 36% Potential Upside Amid Market Challenges 7 November 2025
W.A.G Payment Solutions (WPS.L): Analyst Consensus and Growth Potential with a 10.20% Upside 7 November 2025
ZIGUP PLC ORD 50P (ZIG.L) Stock Analysis: A 37% Upside Potential in the Industrials Sector 7 November 2025
Volution Group PLC (FAN.L) Stock Analysis: Assessing a 12.26% Potential Upside for Investors 7 November 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Evaluating a 36% Potential Upside Amid Market Challenges 7 November 2025
W.A.G Payment Solutions (WPS.L): Analyst Consensus and Growth Potential with a 10.20% Upside 7 November 2025
ZIGUP PLC ORD 50P (ZIG.L) Stock Analysis: A 37% Upside Potential in the Industrials Sector 7 November 2025
Volution Group PLC (FAN.L) Stock Analysis: Assessing a 12.26% Potential Upside for Investors 7 November 2025
AstraZeneca’s Symbicort approved in China as an anti-inflammatory reliever in mild asthma 26 January 2021
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Evaluating a 36% Potential Upside Amid Market Challenges 7 November 2025
W.A.G Payment Solutions (WPS.L): Analyst Consensus and Growth Potential with a 10.20% Upside 7 November 2025
ZIGUP PLC ORD 50P (ZIG.L) Stock Analysis: A 37% Upside Potential in the Industrials Sector 7 November 2025
Volution Group PLC (FAN.L) Stock Analysis: Assessing a 12.26% Potential Upside for Investors 7 November 2025